Xtx Topco LTD Cara Therapeutics, Inc. Transaction History

Xtx Topco LTD

$1.3 Billion
Q3 2024

A detailed history of Xtx Topco LTD transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 94,709 shares of CARA stock, worth $24,624. This represents 0.0% of its overall portfolio holdings.

Number of Shares

94,709

Holding current value

$24,624

% of portfolio

0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.26 - $0.38 $24,624 - $35,989	94,709 New	94,709 $29,000
Q1 2024 May 13, 2024	BUY	$0.52 - $1.05 $4,686 - $9,462	9,012 Added 33.1%	36,236 $32,000
Q4 2023 Feb 13, 2024	BUY	$0.6 - $1.65 $5,430 - $14,934	9,051 Added 49.8%	27,224 $20,000
Q3 2023 Nov 13, 2023	SELL	$1.67 - $3.33 $56,532 - $112,727	-33,852 Reduced 65.07%	18,173 $30,000
Q2 2023 Aug 14, 2023	SELL	$2.83 - $4.94 $157,305 - $274,589	-55,585 Reduced 51.65%	52,025 $147,000
Q1 2023 May 12, 2023	BUY	$4.89 - $12.27 $457,816 - $1.15 Million	93,623 Added 669.36%	107,610 $528,000
Q4 2022 Feb 14, 2023	BUY	$8.88 - $12.77 $124,204 - $178,613	13,987 New	13,987 $150,000

Others Institutions Holding CARA

# of Institutions

Shares Held

12.8M

Call Options Held

Put Options Held

Vanguard Group Inc Valley Forge, PA

2.25M
Shares

$584,716
0.0% of portfolio
Chescapmanager LLC Baltimore, MD

1.7M
Shares

$442,548
0.06% of portfolio
Farallon Capital Management LLC San Francisco, CA

1.56M
Shares

$404,625
0.0% of portfolio
Disciplined Growth Investors Inc Minneapolis, MN

1.11M
Shares

$289,391
0.01% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.11M
Shares

$288,322
0.0% of portfolio

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account